Che Connon

Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million.

CellRev is a bioprocessing British technology company that specializes in developing innovative cell expansion technology to continuously grow, detach, and collect adherent cells. The company is based in Newcastle-upon-Tyne, UK and was founded in 2018 by Che John Connon, Leo Cornelis Groenewegen, and Martina Miotto. The company's technology is used to advance lifesaving treatments and develop a new sustainable food system.

Atelerix Ltd. engages in preserving the viability and functionality of cells at hypothermic temperatures. The company was founded on June 5, 2017 and is headquartered in Cambridge, the United Kingdom.

Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million.